Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gynecology | 21 | 2024 | 528 | 2.420 |
Why?
|
Obstetrics | 20 | 2024 | 667 | 2.120 |
Why?
|
Education, Medical, Undergraduate | 16 | 2022 | 1066 | 1.380 |
Why?
|
Professional Autonomy | 2 | 2019 | 171 | 1.190 |
Why?
|
Curriculum | 20 | 2022 | 3718 | 0.880 |
Why?
|
Clinical Clerkship | 7 | 2020 | 563 | 0.800 |
Why?
|
Teaching | 7 | 2023 | 1169 | 0.770 |
Why?
|
Internship and Residency | 8 | 2024 | 5870 | 0.660 |
Why?
|
Radiation Protection | 1 | 2022 | 425 | 0.630 |
Why?
|
Education, Medical | 8 | 2021 | 1727 | 0.620 |
Why?
|
Gynecologic Surgical Procedures | 2 | 2019 | 304 | 0.600 |
Why?
|
Schools, Medical | 9 | 2022 | 878 | 0.590 |
Why?
|
Trust | 2 | 2019 | 532 | 0.580 |
Why?
|
Clinical Competence | 7 | 2022 | 4783 | 0.570 |
Why?
|
Faculty, Medical | 6 | 2020 | 1192 | 0.570 |
Why?
|
Wakefulness | 1 | 2023 | 1255 | 0.540 |
Why?
|
Students, Medical | 10 | 2022 | 1927 | 0.530 |
Why?
|
Genital Neoplasms, Female | 4 | 2024 | 533 | 0.530 |
Why?
|
Embryo Loss | 1 | 2015 | 55 | 0.520 |
Why?
|
Education, Premedical | 1 | 2015 | 17 | 0.510 |
Why?
|
Professional Competence | 3 | 2015 | 431 | 0.490 |
Why?
|
Social Identification | 1 | 2015 | 106 | 0.470 |
Why?
|
Specialties, Surgical | 1 | 2019 | 388 | 0.470 |
Why?
|
Self Concept | 1 | 2015 | 1039 | 0.330 |
Why?
|
Radiology | 1 | 2022 | 2102 | 0.310 |
Why?
|
Pregnancy Complications, Neoplastic | 3 | 2005 | 255 | 0.300 |
Why?
|
Counseling | 1 | 2015 | 1548 | 0.290 |
Why?
|
Vaginal Neoplasms | 2 | 2004 | 104 | 0.270 |
Why?
|
Hysterectomy | 2 | 2009 | 904 | 0.240 |
Why?
|
Attitude of Health Personnel | 4 | 2019 | 3865 | 0.220 |
Why?
|
Laparoscopy | 2 | 2019 | 2147 | 0.220 |
Why?
|
Multimedia | 1 | 2022 | 74 | 0.200 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2021 | 84 | 0.190 |
Why?
|
California | 6 | 2009 | 1416 | 0.180 |
Why?
|
Educational Measurement | 4 | 2020 | 1248 | 0.180 |
Why?
|
Endometrial Neoplasms | 1 | 2009 | 1357 | 0.170 |
Why?
|
Licensure, Medical | 1 | 2020 | 68 | 0.170 |
Why?
|
Personnel Selection | 1 | 2021 | 193 | 0.160 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 562 | 0.150 |
Why?
|
Abortion, Induced | 1 | 2024 | 460 | 0.150 |
Why?
|
Education, Distance | 1 | 2021 | 258 | 0.150 |
Why?
|
Preceptorship | 1 | 2018 | 56 | 0.150 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5325 | 0.150 |
Why?
|
Ovarian Neoplasms | 4 | 2021 | 4878 | 0.150 |
Why?
|
Physicians | 1 | 2016 | 4591 | 0.150 |
Why?
|
Carcinoma, Small Cell | 1 | 2020 | 416 | 0.150 |
Why?
|
Cultural Diversity | 1 | 2021 | 365 | 0.150 |
Why?
|
Thinking | 1 | 2020 | 319 | 0.140 |
Why?
|
Problem-Based Learning | 1 | 2020 | 352 | 0.140 |
Why?
|
Hypercalcemia | 1 | 2020 | 421 | 0.140 |
Why?
|
Financing, Personal | 1 | 2019 | 309 | 0.140 |
Why?
|
Humans | 50 | 2024 | 760613 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 728 | 0.130 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2005 | 2003 | 0.130 |
Why?
|
Students, Premedical | 1 | 2015 | 3 | 0.130 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1088 | 0.130 |
Why?
|
Mentors | 2 | 2018 | 661 | 0.120 |
Why?
|
Operating Rooms | 2 | 2019 | 789 | 0.120 |
Why?
|
Learning | 5 | 2022 | 1739 | 0.120 |
Why?
|
DNA Helicases | 1 | 2020 | 854 | 0.120 |
Why?
|
Emotional Intelligence | 1 | 2015 | 135 | 0.120 |
Why?
|
Cost of Illness | 2 | 2024 | 1940 | 0.110 |
Why?
|
Neuroblastoma | 1 | 2021 | 1252 | 0.110 |
Why?
|
Models, Educational | 1 | 2015 | 373 | 0.100 |
Why?
|
Ethics, Professional | 1 | 2013 | 100 | 0.100 |
Why?
|
Pelvic Neoplasms | 2 | 2005 | 248 | 0.100 |
Why?
|
Catechols | 1 | 2011 | 62 | 0.100 |
Why?
|
Female | 27 | 2024 | 391246 | 0.100 |
Why?
|
Echinocandins | 1 | 2011 | 51 | 0.100 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1842 | 0.100 |
Why?
|
Uterine Neoplasms | 1 | 2020 | 1439 | 0.090 |
Why?
|
Physical Examination | 1 | 2016 | 1244 | 0.090 |
Why?
|
Pregnancy | 8 | 2024 | 29746 | 0.090 |
Why?
|
Medical Oncology | 1 | 2002 | 2313 | 0.090 |
Why?
|
Socialization | 1 | 2010 | 86 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1575 | 0.080 |
Why?
|
Carcinogens | 1 | 2011 | 449 | 0.080 |
Why?
|
Staff Development | 1 | 2011 | 229 | 0.080 |
Why?
|
Sarcoma | 1 | 2020 | 1786 | 0.080 |
Why?
|
Complementary Therapies | 1 | 2012 | 486 | 0.080 |
Why?
|
United States | 10 | 2020 | 72448 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2004 | 4024 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4550 | 0.070 |
Why?
|
History, 20th Century | 1 | 2016 | 2773 | 0.070 |
Why?
|
Postoperative Complications | 1 | 2009 | 15679 | 0.070 |
Why?
|
Palliative Care | 1 | 2002 | 3607 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2557 | 0.070 |
Why?
|
Health Expenditures | 1 | 2019 | 2362 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2005 | 9278 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2015 | 4775 | 0.070 |
Why?
|
Documentation | 1 | 2012 | 893 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3925 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3164 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5795 | 0.060 |
Why?
|
Physician-Patient Relations | 2 | 2015 | 3242 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1500 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2015 | 14494 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 3018 | 0.060 |
Why?
|
Physician's Role | 1 | 2010 | 918 | 0.060 |
Why?
|
Neoplasm Staging | 3 | 2009 | 11152 | 0.050 |
Why?
|
Lymph Node Excision | 1 | 2009 | 1303 | 0.050 |
Why?
|
Fetal Death | 1 | 2005 | 434 | 0.050 |
Why?
|
School Admission Criteria | 1 | 2024 | 105 | 0.050 |
Why?
|
Interleukin-21 Receptor alpha Subunit | 1 | 2021 | 18 | 0.050 |
Why?
|
Students | 2 | 2022 | 1730 | 0.050 |
Why?
|
Job Application | 1 | 2021 | 38 | 0.050 |
Why?
|
Test Taking Skills | 1 | 2020 | 10 | 0.050 |
Why?
|
Internet | 1 | 2013 | 3078 | 0.040 |
Why?
|
Quality Improvement | 1 | 2015 | 3835 | 0.040 |
Why?
|
Transcription Factors | 1 | 2020 | 12102 | 0.040 |
Why?
|
Carcinoma in Situ | 1 | 2005 | 796 | 0.040 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2003 | 586 | 0.040 |
Why?
|
Cancer Care Facilities | 1 | 2002 | 424 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 2299 | 0.040 |
Why?
|
Male | 6 | 2024 | 359718 | 0.040 |
Why?
|
Faculty | 1 | 2022 | 383 | 0.040 |
Why?
|
Medical Records | 1 | 2004 | 1407 | 0.040 |
Why?
|
Adult | 10 | 2020 | 220007 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2020 | 80345 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2021 | 1342 | 0.040 |
Why?
|
Pregnancy Outcome | 2 | 2005 | 2907 | 0.040 |
Why?
|
Middle Aged | 9 | 2024 | 220359 | 0.040 |
Why?
|
Intergenerational Relations | 1 | 2017 | 68 | 0.030 |
Why?
|
Aged | 7 | 2024 | 169143 | 0.030 |
Why?
|
Prognosis | 3 | 2020 | 29661 | 0.030 |
Why?
|
Brachytherapy | 1 | 2004 | 1238 | 0.030 |
Why?
|
Research Design | 1 | 2011 | 6180 | 0.030 |
Why?
|
Cohort Studies | 4 | 2020 | 41337 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 25941 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2004 | 3618 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1895 | 0.030 |
Why?
|
Infant, Premature | 1 | 2005 | 2092 | 0.030 |
Why?
|
Survival Rate | 1 | 2009 | 12810 | 0.030 |
Why?
|
Endometriosis | 1 | 2003 | 874 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2004 | 8552 | 0.030 |
Why?
|
Self Report | 2 | 2019 | 3711 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1139 | 0.030 |
Why?
|
Computer-Assisted Instruction | 1 | 2017 | 362 | 0.030 |
Why?
|
Survival Analysis | 2 | 2004 | 10185 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2001 | 932 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39262 | 0.030 |
Why?
|
Learning Curve | 1 | 2015 | 231 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2021 | 11481 | 0.030 |
Why?
|
Obstetrics and Gynecology Department, Hospital | 1 | 2012 | 41 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2012 | 58980 | 0.030 |
Why?
|
Pelvis | 1 | 2016 | 743 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2021 | 1455 | 0.020 |
Why?
|
Leukemia Virus, Murine | 1 | 2011 | 94 | 0.020 |
Why?
|
Work Schedule Tolerance | 1 | 2015 | 551 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2015 | 759 | 0.020 |
Why?
|
Texas | 1 | 2012 | 401 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2024 | 3598 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16932 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2021 | 5496 | 0.020 |
Why?
|
Organizational Policy | 1 | 2013 | 429 | 0.020 |
Why?
|
Inpatients | 1 | 2002 | 2580 | 0.020 |
Why?
|
Income | 1 | 2019 | 1875 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2012 | 389 | 0.020 |
Why?
|
Catechol O-Methyltransferase | 1 | 2011 | 251 | 0.020 |
Why?
|
Workload | 1 | 2015 | 847 | 0.020 |
Why?
|
Social Values | 1 | 2010 | 225 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2019 | 2283 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9530 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54306 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3562 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3844 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2019 | 2628 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2015 | 1428 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 3075 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6316 | 0.020 |
Why?
|
Breast | 1 | 2016 | 1963 | 0.020 |
Why?
|
Registries | 1 | 2004 | 8458 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2005 | 26179 | 0.020 |
Why?
|
Insurance, Health | 1 | 2019 | 2501 | 0.020 |
Why?
|
Culture | 1 | 2010 | 622 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14374 | 0.020 |
Why?
|
Adnexa Uteri | 1 | 2005 | 40 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2011 | 3085 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3386 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8512 | 0.020 |
Why?
|
Program Development | 1 | 2011 | 1297 | 0.010 |
Why?
|
Estradiol | 1 | 2011 | 1932 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4571 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5039 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22020 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 11713 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2009 | 64981 | 0.010 |
Why?
|
Program Evaluation | 1 | 2011 | 2493 | 0.010 |
Why?
|
Pregnancy, High-Risk | 1 | 2001 | 119 | 0.010 |
Why?
|
Adolescent | 2 | 2012 | 87809 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12159 | 0.010 |
Why?
|
Maternal Mortality | 1 | 2001 | 300 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23374 | 0.010 |
Why?
|
Maternal Age | 1 | 2001 | 807 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2003 | 1630 | 0.010 |
Why?
|
Communication | 1 | 2012 | 3849 | 0.010 |
Why?
|
Age Distribution | 1 | 2003 | 2893 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40139 | 0.010 |
Why?
|
Infant Mortality | 1 | 2001 | 756 | 0.010 |
Why?
|
Biomedical Research | 1 | 2011 | 3426 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9406 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18413 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81209 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7475 | 0.010 |
Why?
|
Animals | 1 | 2021 | 167960 | 0.010 |
Why?
|
Young Adult | 1 | 2012 | 58748 | 0.000 |
Why?
|
Incidence | 1 | 2003 | 21391 | 0.000 |
Why?
|
Risk Assessment | 1 | 2003 | 24102 | 0.000 |
Why?
|
Risk Factors | 1 | 2001 | 74333 | 0.000 |
Why?
|
Concepts
(209)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(55)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_